Will my psoriasis clear up, or is this how it stays?
Nobody can tell you which. I read the National Psoriasis Foundation, which describes psoriasis as a long-term disease with no cure. What it can do is quiet down for a stretch and come back. A dermatologist can describe what your skin has done so far. That is a different thing from a forecast. Evidence Evidence Evidence
Why this matters
- Sources cited, not yet graded
An overactive immune system speeds up skin-cell growth. Cells that normally take about a month to grow and shed do it in three or four days. I read the AAD on this. It uses the word remission for a stretch with little or no psoriasis, and treats those stretches as something that can become more frequent or less.
Considerations
- Depends on you
None of these sources says how likely a clear stretch is for one person, or how long one lasts. The AAD states plainly that triggers differ from person to person. A quiet year is not a promise. A bad month is not the rest of your life.
Questions for your dermatologist
Looking at my skin and what it has done so far, what pattern do you think you are seeing?
Saving keeps this on your device and needs JavaScript, which is off in this browser.What would you need to see before you called my psoriasis settled?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
What sets a flare off?
People I have heard from ask what sets a flare off, and whether they can head one off. I read the AAD list. It sorts the usual suspects into a short set of categories, and puts a rough delay on several of them. Evidence Evidence Evidence
- Infection, such as strep throat, an earache or bronchitis. A flare is reported 2 to 6 weeks later.
- Skin injury, such as a cut, scrape, sunburn, bug bite, tattoo or piercing. A new patch is reported near that spot about 10 to 14 days later.
- Stress.
- Starting certain medicines, including lithium, antimalarial drugs, strong corticosteroids and some blood pressure drugs. A flare is reported about 2 to 3 weeks after starting.
- Cold, dry weather. Sunburn and time in air conditioning are named too.
- Smoking, or being around secondhand smoke.
- Drinking daily, or more than two drinks on several days a week, which the AAD links to treatment working less well.
Why this matters
- Sources cited, not yet graded
I checked NIAMS, which records the same picture from the other direction, by subtype. It names an upper respiratory infection such as strep throat ahead of guttate outbreaks.
Considerations
- Depends on you
These are categories, not a ranked list and not a complete one. Neither page counts how often each trigger is reported. Plenty of flares never get a cause anyone can name, and that is not something you missed.
Questions for your dermatologist
Given my work and where I live, which of these categories is worth my attention?
Saving keeps this on your device and needs JavaScript, which is off in this browser.If I come down with strep or get a deep cut, when would you want to hear from me?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
Does stopping treatment bring it back?
It can, and how you stop matters. I read the National Psoriasis Foundation page on steroids, which reports that abruptly stopping a topical steroid can cause a psoriasis flare. The AAD lists strong corticosteroids among the medicines whose use can trigger one. Stopping or changing a prescribed treatment belongs in a conversation with whoever prescribed it. Evidence Evidence Evidence Evidence Evidence
Why this matters
- Sources cited, not yet graded
I read NIAMS on the less common forms. It records that erythrodermic psoriasis, a form covering most of the skin, can be triggered by certain medicines including corticosteroids. It records that pustular psoriasis can be triggered by medicines, infections, stress or certain chemicals. I checked NICE too, which treats erythroderma and generalised pustular psoriasis as reasons for same-day specialist assessment.
Considerations
- Depends on you
None of these sources counts how often a flare follows stopping. None of them describes a way to come off a treatment, and none is copied here. NICE is UK guidance and does not set US labeling or coverage.
Questions for your dermatologist
If my skin clears on this treatment, what happens to it after that?
Saving keeps this on your device and needs JavaScript, which is off in this browser.What should I watch for if we ever change or stop what I am on?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
How can I tell a clearing plaque from a flaring one?
Watch the four things treatment is described as changing. The AAD says medicine applied to the skin reduces redness, swelling, scaling and itch. A plaque that is settling loses scale, flattens, and itches less. A flare runs the other way: new patches, or patches you already had spreading and getting thicker. Evidence Evidence Evidence
Why this matters
- Sources cited, not yet graded
I read the NIAMS description of a plaque: thick, discolored, scaly skin that itches or burns, with dry, cracked skin that can itch or bleed. Those are the features to compare against. The AAD treats a run of time on a skin treatment with no improvement as a signal to go back to the prescriber rather than wait it out.
Considerations
- Depends on you
None of this is a score you can settle at home. Skin can stay a different color after a plaque has flattened, and that mark is not the same thing as an active plaque. Photos taken weeks apart are easier to compare than memory, but a photo is not a measurement.
Questions for your dermatologist
When you look at this patch, what tells you it is settling rather than just calmer today?
Saving keeps this on your device and needs JavaScript, which is off in this browser.How much better does this have to look before either of us counts it as a real change?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
What if it keeps coming back anyway?
Then the plan is worth another look, and asking for one is normal. Patches that return are not a verdict on you, and not proof that nothing works. Evidence Evidence Evidence
Why this matters
- Sources cited, not yet graded
I read the NICE guideline. It assesses psoriasis across the skin, the nails, high-impact sites, the effect on daily life and any joint concerns, then maps treatment options against that whole picture. The National Psoriasis Foundation says to bring a symptom record to the appointment and share it, so a vague bad stretch becomes something specific.
Considerations
- Depends on you
I cannot decide when you switch, pause or stay put. NICE is UK guidance and sets no US sequence or coverage. What your record means depends on your health history and the clinician responsible for your care.
Questions for your dermatologist
What would make you suggest changing direction rather than waiting this out?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Which parts of my week would you want to hear about that I have not been mentioning?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
Evidence and update context
This optional layer shows the evidence boundary I reviewed as of 2026-09-19.
- What this evidence supports
- An overactive immune system speeds up skin-cell growth. Cells that normally take about a month to grow and shed do it in three or four days. I read the AAD on this. It uses the word remission for a stretch with little or no psoriasis, and treats those stretches as something that can become more frequent or less.
- What it does not establish
- None of these sources says how likely a clear stretch is for one person, or how long one lasts. The AAD states plainly that triggers differ from person to person. A quiet year is not a promise. A bad month is not the rest of your life.
Evidence behind this page
Sources
Each evidence badge opens the source and its limits. The full list stays available here.
- National Institute of Arthritis and Musculoskeletal and Skin DiseasesPatient education · Patient education, tier 5Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports that poor sleep quality is a listed symptom of psoriasis. Also lists patches of thick, red, scaly skin that itch or burn, and dry, cracked skin that itches or bleeds. Supports that psoriasis carries risk for mental-health concerns including low self-esteem, anxiety, and depression. Supports that managing common triggers, such as stress and skin injuries, can help keep symptoms under control. Supports, by subtype, that guttate psoriasis outbreaks are often triggered by an upper respiratory infection such as strep throat. Also supports that pustular psoriasis symptoms can be triggered by medications, infections, stress, or certain chemicals. Also supports that erythrodermic psoriasis can be triggered by a bad sunburn or certain medications including corticosteroids. Also supports, by subtype, that inverse psoriasis appears as smooth patches of inflamed skin in skin folds. It names the armpits, the groin, and under the breasts as those folds. It records that rubbing and sweating can make inverse psoriasis worse.
What it does not support
Does not give a percentage of patients affected. Does not measure how much sleep is lost. Does not establish that treating the skin fixes the sleep problem for any one person. Its trigger information is organized by psoriasis subtype, not as one general list for plaque psoriasis specifically. It counts nothing for inverse psoriasis either. It gives no share of people affected in a fold or genital site, and it names no treatment for one.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- American Academy of DermatologyPatient education · Patient education, tier 5Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports that stress can trigger a psoriasis flare. Supports that skin injury - a cut, scrape, sunburn, tattoo, piercing, bug bite, or shaving nick - can trigger a flare near or at that spot. Typically this appears about 10 to 14 days after the injury. Supports that an infection such as strep throat, an earache, or bronchitis can trigger a flare, reported 2 to 6 weeks later. Supports that starting a medication - including lithium, antimalarial drugs, strong corticosteroids, or some blood pressure drugs - can trigger a flare about 2 to 3 weeks after starting it. Supports that cold, dry weather (such as winter or fall) can worsen flares, and that sunburn or spending time in air conditioning can also worsen them. Supports that smoking, or spending time around secondhand smoke, is a reported trigger. Supports that drinking daily, or more than two drinks on several days a week, can make psoriasis treatment have little or no effect. Supports that triggers differ from person to person.
What it does not support
Does not cite a specific study for its trigger list or timing windows, and does not state how many patients experience each trigger. This page displays no revision date; the date recorded here matches the same AAD psoriasis disease microsite's treatment-and-diagnosis page, checked the same day. Does not establish that avoiding a listed trigger will prevent a flare for any one person.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- American Academy of DermatologyPatient education · Patient education, tier 5Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports that a skin injury can trigger a new patch of psoriasis near the injury site. Examples: a cut, scrape, sunburn, scratch, bruise, bug bite, new tattoo, or piercing. Supports that this typically shows up about 10 to 14 days after the injury, including after a shaving cut. Supports treating injuries promptly, avoiding scratching, using insect repellent, and asking a dermatologist before a tattoo or piercing.
What it does not support
Does not give a byline or last-reviewed date on the page itself. Does not say every injury causes a flare, and gives no individual risk estimate.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- American Academy of DermatologyPatient education · Patient education, tier 5Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports that quitting smoking is linked to fewer flares and less palmoplantar psoriasis. Supports that it is linked to more remissions. Supports that quitting also lowers the risk of heart, blood vessel, liver, and gum disease. Supports that it lowers the risk of an autoimmune disease like Crohn's disease. Supports the caution that a nicotine patch can make psoriasis flare, and to ask a dermatologist before using one. Supports that limiting alcohol is linked to treatment working better and lasting longer. Supports that it is linked to a lower risk of psoriatic arthritis in women. Supports that it is linked to a lower risk of fatty liver disease and liver damage from some psoriasis medications. Supports a named threshold: more than 2 drinks a day for men, or more than 1 for women. Supports that above that threshold, treatment may stop working, work less well, or lead to fewer remissions.
What it does not support
Does not give a percentage or timeline for one person. The page shows no visible byline or update date. The site copyright year, 2026, is used here.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- National Psoriasis FoundationPatient education · Patient education, tier 5Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports that tracking symptoms and common triggers over time can help a person figure out their own specific triggers. Supports naming stress, alcohol, and diet as examples of common triggers to watch for. Supports naming discolored skin patches and itching as psoriasis symptoms, and joint swelling and fatigue as psoriatic arthritis symptoms, to watch for. Supports using a worksheet to record daily symptoms and their severity, and sharing that worksheet with a health care provider.
What it does not support
Does not give a percentage or timeline for how much tracking changes any one outcome. Does not name every possible trigger - stress, alcohol, and diet are examples, not a complete list. Does not measure whether tracking itself helps or burdens a given person.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- National Psoriasis FoundationPatient education · Patient education, tier 5Independence not established
- Published
- SteadySkin last checked
What this source can and cannot tell you
Why the independence label says this: The organization publishes patient education, but the editorial and funding independence of this page was not separately reviewed.
What this source supports
Supports that psoriasis is an immune-mediated disease. It causes inflammation in the body. Raised plaques and scale on the skin are the visible sign. Supports that an overactive immune system speeds up skin-cell growth. Skin cells normally take about a month to grow and shed. With psoriasis they do so in three or four days. Supports that psoriasis is a chronic, long-term disease with no cure.
What it does not support
Does not predict whether one person will clear, stay the same, or flare. Does not give a share of people who reach a period with little or no psoriasis, or how long such a period lasts. The page shows no visible byline or update date. The site copyright year, 2026, is used here.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- National Institute for Health and Care ExcellenceGuideline · Regulatory / guideline, tier 1Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports psoriasis assessment across skin, nails, high-impact sites, life impact and joint concerns; same-day specialist assessment for generalised pustular psoriasis or erythroderma; and a treatment map that includes topical, phototherapy and systemic options.
What it does not support
It is UK guidance and does not diagnose a reader, create a US treatment sequence, determine personal urgency from a description, or establish current US labeling or coverage.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- American Academy of DermatologyPatient education · Patient education, tier 5Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports that topical corticosteroids reduce redness, swelling, scaling and itch, and slow skin-cell growth. They come in strengths from very mild to extremely strong and are typically applied twice daily. Strong products on thin skin such as the face carry skin-thinning, spider-vein and stretch-mark risk. Most people see results with short twice-daily use, and no improvement after four to six weeks is a signal to return to the prescriber.
What it does not support
The page does not display its own separate revision date; the date recorded here matches the same AAD psoriasis treatment section’s dated overview page checked the same day. It does not name potency classes by number, give a percentage of people who improve, or set a maximum course length.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- National Psoriasis FoundationPatient education · Patient education, tier 5Independence not established
- Published
- SteadySkin last checked
What this source can and cannot tell you
Why the independence label says this: The organization provides patient education, but its editorial and funding independence for this page was not independently reviewed.
What this source supports
Supports that topical steroids range from super-potent to least potent, and that guidance advises not using one for longer than three weeks without checking with a clinician. Side effects include skin thinning, pigment change, easy bruising, stretch marks, redness and dilated blood vessels. Systemic absorption is a risk with widespread, prolonged or occluded use, and abruptly stopping a topical steroid can cause a psoriasis flare.
What it does not support
It does not name which specific product falls in which potency class, quantify how often a side effect occurs, or set a course length for any specific product or body site.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.